Trial intelligence / Profile preview

NeuroCell-PD in Parkinson's Disease

NCT00226460Phase 2Completed

Sponsor
Sanofi
Start
Aug 1997
Modality
Cell Therapies
Countries
1
01

Overview

A Phase 2 trial of NeuroCell-PD in Parkinson's disease (PD), sponsored by Sanofi. Started Aug 1997; status: completed.

02

Drugs

NeuroCell-PD
03

Conditions

Parkinson's disease (PD)

Beyond the preview

Go deeper on NCT00226460.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00226460.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call